Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof
US5240703A · kind A · utility
78Cited by
13References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 1, 1991 |
| Grant date | Aug 31, 1993 |
| Priority date | — |
| Expiry date | Mar 1, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/815
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an attenuated, genetically-engineered pseudorabies virus designated S-PRV-155 (ATCC Accession No. VR 2311). A vaccine is provided which comprises an effective immunizing amount of S-PRV-155 and a suitable carrier. A method of immunizing an animal against disease caused by pseudorabies virus is also provided which comprises administering to the animal an effective immunizing dose of the vaccine. The present invention also provides a method for distinguishing an animal vaccinated with the vaccine of the present invention from an animal infected with a naturally-occurring, wild-type pseudorabies virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.